Viropro, Inc. engages in the development, manufacture and sale of biopharmaceutical products. The company is headquartered in Irvine, California and currently employs 34 full-time employees. The company went IPO on 2001-06-21. The firm conducts operations primarily through its subsidiary, Alpha Biologics Sdn Bhd (Alpha) located in Penang, Malaysia. The firm intends to offer solution to the biopharma industry from drug concept through to product manufacturing. The Alpha facility consists of approximately 50,000 square feet of research and production space. The Alpha facility is designed to support the scale-up and manufacture of monoclonal antibodies.
Follow-Up Questions
¿Qué tal es el rendimiento del precio de la acción VPRO?
El precio actual de VPRO es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Viropro Inc?
Viropro Inc pertenece a la industria N/A y el sector es N/A
¿Cuál es la capitalización bursátil de Viropro Inc?
La capitalización bursátil actual de Viropro Inc es $0
